Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Grignard Reaction and Halogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN119080592A offers safer synthesis for Baloxavir intermediates with high purity and reduced environmental impact for supply chain stability.